Switch to:
More From Other Websites
VIVUS to Regain Commercial Rights for Stendra from Sanofi Mar 28 2017
Orexigen Inks Commercialization Deal for Contrave, Stock Up Mar 28 2017
Vivus Inc. stock rises 4.6% after regaining certain commercial rights for Stendra from Sanofi Mar 27 2017
Vivus Inc. stock rises 4.6% after regaining certain commercial rights for Stendra from Sanofi Mar 27 2017
VIVUS INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Regulation FD... Mar 27 2017
8:32 am Vivus reaches an agreement w/ Sanofi (SNY) for Sanofi to... Mar 27 2017
VIVUS, Inc. Reacquires STENDRA(R) (Avanafil) Commercial Rights from Sanofi Mar 27 2017
7 Most Popular Diet Pills That Work Fast Without Exercise Mar 15 2017
VIVUS, Inc. :VVUS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 15, 2017 Mar 15 2017
VIVUS INC Financials Mar 14 2017
Top 10 Long/Short Estimize Signal Scores [Week 3/13] Mar 14 2017
VIVUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Mar 13 2017
Markets Rally Late to Close in the Green: Today's Research Reports on Immunomedics and VIVUS Mar 10 2017
VIVUS (VVUS) Beats on Q4 Earnings, Revenues Increase Y/Y Mar 09 2017
Edited Transcript of VVUS earnings conference call or presentation 8-Mar-17 9:30pm GMT Mar 08 2017
Vivus posts 4Q profit Mar 08 2017
Vivus posts 4Q profit Mar 08 2017
VIVUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Mar 08 2017
VIVUS Reports Fourth Quarter and Full Year 2016 Financial Results Mar 08 2017
VIVUS INC Files SEC form 10-K, Annual Report Mar 08 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK